Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care

NATerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

February 18, 2020

Study Completion Date

February 18, 2020

Conditions
DiabetesDiabetic FootDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Interventions
DEVICE

Cytal Wound Matrix 1-Layer

Cytal® Wound Matrix 1-Layer is composed of a porcine (pig) derived extracellular matrix known as urinary bladder matrix. It is intended for the management of a variety of wounds.The individual device is intended for one time use.

OTHER

Standard of Care (SOC)

Standard of care (SOC) is defined as the usual care a licensed health care provider would give patients to treat diabetic foot ulcers or wounds. SOC associated procedures and policies may vary across clinical settings.

Trial Locations (3)

20782

MedStar Health Research Institute, Hyattsville

70112

Louisiana State University Health Science Center (LSUHSC), New Orleans

93710

Limb Preservation Platform, Inc., Fresno

All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT03626623 - Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care | Biotech Hunter | Biotech Hunter